Osteoporosis International

, Volume 27, Issue 7, pp 2197–2206

Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group

  • S. L. Silverman
  • E. S. Kupperman
  • S. V. Bukata
  • Members of IOF Fracture Working Group
Original Article

Abstract

Summary

We used the RAND UCLA appropriateness method to decide appropriateness of use of osteoporosis medication after incident fracture and potential for fracture healing and make suggestions for trial design for clinical and preclinical research.

Purpose

To develop appropriateness criteria to assist in the use and study of osteoporosis medications in patients with recent fracture and in the potential use of osteoporosis medications to enhance delayed fracture healing. To promote further research by suggesting preclinical and clinical trial design for studies where fracture healing is the endpoint.

Methods

Design: RAND/UCLA appropriateness method (RUAM). Participants: A panel of experts, both members and non-members of the International Osteoporosis Foundation Fracture Working Group, were identified consisting of geriatricians, rheumatologists, orthopedists, endocrinologists, and internists. This resulted in a round 1 panel of 15 panelists, round 2 panel of 15 members, and a round 3 panel of 14 members. Main outcome measure: Agreement on statements and scenarios using RUAM. Three rounds of voting by panelists took place. Agreement in a third round was reached for 111 statements and scenarios, measured by median panel ratings and the amount of dispersion of panel ratings, based on the interpercentile range.

Results

An expert panel validated a set of statements and scenarios about the use of osteoporosis medications after incident fracture and use of these medications to enhance delayed fracture healing and made recommendations for study designs to investigate the effect of osteoporosis medications on fracture healing.

Conclusions

The result of this exercise is intended to assist in improving patient care by identifying the appropriateness of use of osteoporosis medications after fracture and in fracture healing and to make suggestions for further preclinical and clinical research.

Keywords

Fracture healing Osteoporotic fracture Trial design 

References

  1. 1.
    The Rand UCLA Appropriateness method user’s manual (2001) Rand Corporation, Los AngelesGoogle Scholar
  2. 2.
    Hemingway H, Crook AM, Banerjee S, Dawson JR, Feder G, Magee PG, Wood A, Philpott S, Timmis A (2001) Hypothetical ratings of coronary angiography appropriateness: are they associated with actual angiographic findings, mortality, and revascularisation rate? The ACRE study. Heart 85:672–679CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Tay WH, de Steiger R, Richardson M, Gruen R, Balogh ZJ (2014) Health outcomes of delayed union and nonunion of femoral and tibial shaft fractures. Injury 45(10):1653–1658CrossRefPubMedGoogle Scholar
  4. 4.
    Schmidmaier G, Schwabe P, Wildemann B, Haas NP (2007) Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury 38(Suppl 4):S35–S41CrossRefPubMedGoogle Scholar
  5. 5.
    Argintar E, Triantafillou K, Delahay J, Wiesel B (2012) The musculoskeletal effects of perioperative smoking. J Am Acad Orthop Surg 20:359–363CrossRefPubMedGoogle Scholar
  6. 6.
    Sloan A, Hussain I, Maqsood M, Eremin O, El-Sheemy M (2010) The effects of smoking on fracture healing. Surgeon 8:111–116CrossRefPubMedGoogle Scholar
  7. 7.
    Hernandez RK, Do TP, Critchlow CW, Dent RE, Jick SS (2012) Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database. Acta Orthop 83:653–660CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bhandari M, Fong K, Sprague S, Williams D, Petrisor B (2012) Variability in the definition and perceived causes of delayed unions and nonunions: a cross-sectional, multinational survey of orthopedic surgeons. J Bone Joint Surg Am 94:e1091–e1096CrossRefPubMedGoogle Scholar
  9. 9.
    Colon-Emeric CX, Nordslettern L, Olson S, Major N, Boonen S, Haentjens P, Mesenbrink P, Magaziner J, Adachi J, Lyles KW, et al. (2011) Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int 22(8):2329–36Google Scholar
  10. 10.
    Schindeler A, McDonald MM, Bokko P, Little DG (2008) Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 19:459–466CrossRefPubMedGoogle Scholar
  11. 11.
    Larsson S, Fazzalari NL (2014) Anti-osteoporosis therapy and fracture healing. Arch Orthop Trauma Surg 134(2):291–297CrossRefPubMedGoogle Scholar
  12. 12.
    Molvik H, Khan W (2015) Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int 26:1251–1260CrossRefPubMedGoogle Scholar
  13. 13.
    Ng AJ, Yue B, Joseph S, Richardson M (2014) Delayed/non-union of upper limb fractures with bisphosphonates: systematic review and recommendations. ANZ J Surg 84:218–224CrossRefPubMedGoogle Scholar
  14. 14.
    Uchiyama S, Itsubo T, Nakamura K, Fujinaga Y, Sato N, Imaeda T, Kadoya M, Kato H (2013) Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time. Bone Joint J 95:1544–1550CrossRefPubMedGoogle Scholar
  15. 15.
    Yue B, Ng A, Tang H, Joseph S, Richardson M (2015) Delayed healing of lower limb fractures with bisphosphonate therapy. Ann R Coll Surg Engl 97:333–338CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Li YT, Cai HF, Zhang ZL (2015) Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 26:431–434CrossRefPubMedGoogle Scholar
  17. 17.
    Adami S, Libanati C, Boonen S, Cummings SR, Ho PR, Wang A, Siris E, Lane J, FREEDOM Fracture-Healing Writing Group (2012) Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. J Bone Joint Surg 94:2113–2119CrossRefPubMedGoogle Scholar
  18. 18.
    Amanat N, McDonald M, Godfrey C, Bilston L, Little D (2007) Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J Bone Miner Res 22:867–876CrossRefPubMedGoogle Scholar
  19. 19.
    Andreassen TT,Ejersted C, Oxlund H (1999) Intermittent parathyroid (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14:960–8Google Scholar
  20. 20.
    Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak B, Einhorn TA (2005) Enhancement of experimental fracture healing by systemic administration of human parathyroid hormnone (PTH 1–34). 87: 731–41Google Scholar
  21. 21.
    Nakajima A, SHimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low dose human parathyroid hormone (1–34). J Bone Miner Res 17:2038–2047CrossRefPubMedGoogle Scholar
  22. 22.
    Manabe T, Mori S, Mashiba T, Kaji Y, Iwata K, Komatsubara S, Seki A, Sun YX, Yamamoto T (2007) Human parathyroid hormone (1–34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone 40:1475–1482CrossRefPubMedGoogle Scholar
  23. 23.
    Zhang D, Potty A, Vyas P, Lane J (2014) The role of recombinant PTH in human fracture healing: a systematic review. J Orthop Trauma 28:57–62CrossRefPubMedGoogle Scholar
  24. 24.
    Rubery PT, Bukata SV (2010) Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases. J Spinal Disord Tech 23:151–155CrossRefPubMedGoogle Scholar
  25. 25.
    Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, García-Hernández PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC (2010) Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 25:404–414CrossRefPubMedGoogle Scholar
  26. 26.
    Aspenberg P, Johansson T (2010) Teriparatide improves early callus formation in distal radial fractures. Acta Orthop 81:234–236CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Peichl P, Holzer LA, Maier R, Holzer G (2011) Parathyroid hormone 1–84 accelerates fracture healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am 93:1583–1587CrossRefPubMedGoogle Scholar
  28. 28.
    Moon SW, Lee DH, Kim YC, Kim YB, Lee SJ, Kim JW (2012) Parathyroid hormone 1–34 (teriparatide) treatment in pelvic insufficiency fractures - a report of two cases. J Bone Metab 19:147–151CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Mancilla EE, Brodsky JL, Mehta S, Pignolo RJ, Levine MA (2015) Teriparatide as a systemic treatment for lower extremity nonunion fractures: a case series. Endocr Pract 21:136–142CrossRefPubMedGoogle Scholar
  30. 30.
    Huang TW, Yang TY, Huang KC, Peng KT, Lee MS, Hsu RW (2015) Effect of teriparatide on unstable pertrochanteric fractures. Biomed Res Int 2015:568390. doi:10.1155/2015/568390, Epub 2015 Feb 10 PubMedPubMedCentralGoogle Scholar
  31. 31.
    Park JH, Kang KC, Shin DE, Koh YG, Son JS, Kim BH (2014) Preventative effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture. Osteoporos Int 25:613–618CrossRefPubMedGoogle Scholar
  32. 32.
    Ohtori S, Inoue G, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Miyagi M, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Takaso M, Ozawa T, Takahashi K, Toyone T (2012) Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine 37:E1464–E1468CrossRefPubMedGoogle Scholar
  33. 33.
    European Medicine Agency (2013) Recommendations to restrict the use of Protelos/Osseor (strontium ranelate). www.ema.europa.edu/docs/en_GB/document_library/Press_release/2013/04/wc500142507.pdfAccessed May 25,2015
  34. 34.
    Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A (2010) Strontium ranelate enhances callus strength more than PTH 1–34 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 86:82–89CrossRefPubMedGoogle Scholar
  35. 35.
    Li YF, Luo G, Zhu S, Li JH, Hu J (2010) Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. Osteoporos Int 21:1889–1897CrossRefPubMedGoogle Scholar
  36. 36.
    Oztkuran KE, Demir B, Yucel I, Cakici H, Yilmaz F, Haberal A (2011) Effect of strontium ranelate on fracture healing in the osteoporotic rat. J Orthop Res 29:138–142CrossRefGoogle Scholar
  37. 37.
    Arlot ME, Jiang Y, Genant HK, Zhao J, Burt-Pichat B, Roux JP et al (2008) Histomorphometric and microCT analysis of bone biopsies from postmenopausal woment treated with strontium ranelate. J Bone Miner Res 23:215–222CrossRefPubMedGoogle Scholar
  38. 38.
    Aslam MZ, Khan MA, Chinoy MA, Jillani SA, Sultan SA, Ahmed SK (2014)Significance of strontium ranelate in healing of surgically fixed tibial diaphyseal fractures treated with strontium ranelate vs placebo; a randomised double blind controlled trial. 64(12 Suppl 2):S123-6Google Scholar
  39. 39.
    Scaglione M, Fabbri L, Casella F, Guido G (2015) Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures. Osteoporos IntGoogle Scholar
  40. 40.
    Feng G, Chang-Qing Z, Yi-Min C, Xiao-Lin L (2015) Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats. Int Immunopharmacol 24:7–13CrossRefPubMedGoogle Scholar
  41. 41.
    Virk MS, Alaee F, Tang H et al (2013) Systemica dministration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model. J Bone Joint Surg Am 95:694–701CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Soung DY, Gentile MA, Duong LT, Drissi H (2013) Effects of pharmacologic inhibition of cathepsin K on fracture repair in mice. Bone 5:248–255CrossRefGoogle Scholar
  43. 43.
    Hankenson KD, Zimmerman G, Marcucio R (2014) Biological perspectives of delayed fracture healing. Injury 45(Suppl 2):S8–S15CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Bhandari M, Guyatt GH, Swiontkowski MF, Tornetta P, Sprague S, Schemitsch EH (2002) A lack of consensus in the assessment of fracture healing among orthopedic surgeons. J Orthop Trauma 16:562–566CrossRefPubMedGoogle Scholar
  45. 45.
    Bhandari M, Fong K, Sprague S, Williams D, Petrisor B (2012) Variability in the definition and perceived causes of delayed unions and nonunions: a cross-sectional, multinational survey of orthopaedic surgeons. J Bone Joint Surg Am 94(15):e 1091–e 1096CrossRefGoogle Scholar
  46. 46.
    Morshed S, Corrales L, Genant H, MIclau T (2008) Outcomes assessment in clinical trials of fracture-healing. J Bone Joint Surg 90(Suppl 1):62–67CrossRefPubMedGoogle Scholar
  47. 47.
    Axelrad TW, Einhorn TA (2011) Use of clinical assessment tools in the evaluation of fracture healing. Injury 42(3):301–305CrossRefPubMedGoogle Scholar
  48. 48.
    Corrales L, Morshed S, Bhandari M, Miclau T (2008) Variability in the assessment of fracture healing in orthopaedic trauma studies. J Bone Joint Surg Am 90:1862–1868CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Kooistra BW, Sprague S, Bhandarim, Schemitsch EH (2010) Outcomes in fracture healing trials: a primer. J Orthop Trauma 24:S71–S75CrossRefPubMedGoogle Scholar
  50. 50.
    Bhandari M, Chiavaras MM, Parasu N, et al. (2013) Radiographic union score for hip substantially improves agreements between surgeons and radiologists. BMC Musculoskelet Disord 14: article 70Google Scholar
  51. 51.
    Chiavaras MM, Bain S, Choudur H et al (2013) The radiographic union score for hip (RUSH); the use of a checklist to evaluate hip fracture healing improves agreement between radiologists and orthopedic surgeons. Skelet Radiol 42:1079–1088CrossRefGoogle Scholar
  52. 52.
    Whelan DB, Bhandari M, Stephen D et al (2010) Development of the radiographic union score for tibial fractures for the assessment of tibial fracture healing after intramedullary fixation. J Trauma 68:629–632CrossRefPubMedGoogle Scholar
  53. 53.
    Nakashima H, Yukawa Y, Ito K, Horie Y, Machino M, Kanbara S, Morita D, Imagama S, Ishiguro N, Kato F (2011) Extension CT scan: its suitability for assessing fusion after posterior lumbar interbody fusion. Eur Spine J 20(9):1496–1502CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    McLane HC, Berkowitz AL, Patenaude BN, McKenzie ED, Wolper E, Washlster S, Fink G, Mateen FJ (2015) Availability, accessibility and affordability of neurodiagnostic tests in 37 countries. Neurology 85:1614–1622CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Mills LA, Simpson AH (2012) In vivo models of bone repair. J Bone Joint Surg 94:865–874CrossRefGoogle Scholar
  56. 56.
    Peric M, Dumic-Cule I, Grcevic D, Matijasic M, Verbanac D, Paul R, Grgurevic L, Trkulia V, Bagi CM, Vukicevic S (2015) The rational use of animal models in the evaluation of novel bone regenerative therapies. Bone 70:73–86CrossRefPubMedGoogle Scholar
  57. 57.
    Cortet B (2011) Bone repair in osteoporotic bone: postmenopausal and cortisone-induced osteoporosis. Osteoporos Int 22:2007–2010CrossRefPubMedGoogle Scholar
  58. 58.
    Schilcher J, Koeppen V, Aspenberg P (2014) Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med 371:974–976CrossRefPubMedGoogle Scholar
  59. 59.
    Khow KS, Yong TY (2015) Atypical femoral fracture in a patient treated with denosumab. J Bone Miner Metab 33(3):355–358CrossRefPubMedGoogle Scholar
  60. 60.
    Adler RA, Fuleihan GE, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R, Pignolo RJ, Sellmeyer DE (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society of Bone and Mineral Research. J Bone Miner Res 31(1):16–35CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Chiang CY, Zebaze RM, Ghasem-Zadeh A, Iuliano-Burns S, Hardidge A, Seeman E (2013) Teriparatide improves bone quality and healing of atypical femoral fracture associated with bisphosphonate therapy. Bone 52(1):360–365CrossRefPubMedGoogle Scholar
  62. 62.
    Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y (2015) Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab 33(5):553–559CrossRefPubMedGoogle Scholar
  63. 63.
    Anam EA, Rach F, Gloriex FH, Fassier F, Hamdy R (2015) Osteotomy healing in children with osteogenesis imperfecta receiving bisphosphonate treatment. J Bone Miner Res 30(8):1362–1368CrossRefPubMedGoogle Scholar
  64. 64.
    Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 19(11):1779–1786CrossRefPubMedGoogle Scholar
  65. 65.
    Pizones J, Plotkin H, Parra-Garcia JI, Alvarez P, Gutierrez P, Bueno A, Fernandez-Arroyo A (2005) Bone healing in children with osteogenesis imperfecta treated with bisphosphonates. J Pediatr Orthop 25(3):332–335CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2016

Authors and Affiliations

  • S. L. Silverman
    • 1
    • 2
  • E. S. Kupperman
    • 3
  • S. V. Bukata
    • 3
  • Members of IOF Fracture Working Group
  1. 1.Cedars-Sinai Medical CenterLos AngelesUSA
  2. 2.David Geffen School of MedicineUCLALos AngelesUSA
  3. 3.UCLA Department of OrthopedicsSanta MonicaUSA

Personalised recommendations